Home » Kelun Pharmaceutical: Launched an employee stock ownership plan to grant no more than 9 people a maximum of 1,194,930 shares_Stock_Company_Announcement

Kelun Pharmaceutical: Launched an employee stock ownership plan to grant no more than 9 people a maximum of 1,194,930 shares_Stock_Company_Announcement

by admin

Original title: Kelun Pharmaceutical: Launched an employee stock ownership plan to grant no more than 9 people a maximum of 1,194,930 shares

Shanghai Securities News China Securities News (Reporter Li Xingcai) Kelun Pharmaceutical announced at noon on November 30 that in order to cooperate with the company’s mid- and long-term development strategic plan, establish and improve the benefit-sharing mechanism for employees and shareholders, the company launched an employee stock ownership plan.

Specifically, the scope of the holders of this employee stock ownership plan is the company’s (including holding subsidiaries) senior managers, supervisors and core employees, and the total number does not exceed 9. Employee stock ownership plan stock sources include company stocks repurchased by the company’s special repurchase account and company stocks that are planned to be purchased through the secondary market (including through block trades, centralized bidding transactions, etc.) or other methods permitted by laws and regulations.

Among them, the employee stock ownership plan proposed to be transferred to the company to repurchase no more than 531,665 shares, accounting for approximately 0.0373% of the company’s total equity; The annual average transaction price is 19.6 yuan per share). The upper limit of the stocks that can be purchased and held by this employee stock ownership plan is 1,194,930 shares, and the total purchase amount does not exceed 13 million yuan.

Kelun Pharmaceutical announced that the lock-up period of this employee stock ownership plan is 12 months, and it will be unlocked in 3 phases on the premise that relevant conditions are met. The unlocking ratio is 30%, 40%, and 30%.

See also  Economic operation maintains a recovery trend——National Development and Reform Commission responds to current hot issues in economic operation- China Daily

Among them, there are no company-level and individual-level performance appraisal requirements for the stocks purchased by the employee stock ownership plan through the secondary market, and the rights and interests of this part of the stock (including the rights and interests of the cash dividends obtained by the part of the stock) after unlocking in installments belong to all the holders all. For stocks acquired through repurchase accounts, the company has set up performance evaluation indicators for the three unlocking periods: the net profit attributable to shareholders of listed companies in 2021, 2022, and 2023 shall not be less than 1.050 billion yuan and 1.2 billion yuan respectively. , 1.44 billion yuan, and set up evaluation conditions for the personal performance of employees.

Kelun Pharmaceutical also announced that it plans to launch an equity incentive plan. The number of restricted stocks planned to be granted to incentive objects is 5.002634 shares, accounting for 0.3510% of the company’s total equity on the date of the announcement of the draft incentive plan. A total of 416 people were awarded by the incentive plan, and the award price was RMB 10 per share.Return to Sohu to see more

Editor:

Disclaimer: The opinions of this article only represent the author himself. Sohu is an information publishing platform. Sohu only provides information storage space services.

.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy